Ocular Therapeutix

Ocular Therapeutix OCUL Stock

$5.94   -1.328900%
Add to favorites
Market Cap
$1.31B
LOW - HIGH [24H]
$5.92 - $6.35
VOLUME [24H]
$3.67M
P/E Ratio
0
Earnings per share
-$1.44
ISIN
US67576A1007
Price   Prediction

Ocular Therapeutix Price Chart

Sorry, that's all we've gotfor now...

Ocular Therapeutix (OCUL) stock price today is 5.94 USD on Tech Market Middle (-1.33% on the day). Updated .

Ocular Therapeutix OCUL Financial and Trading Overview

Ocular Therapeutix stock price 5.94 USD
Previous Close 6.01 USD
Open 6 USD
Bid 6.26 USD x 200
Ask 10.89 USD x 200
Day's Range 5.81 - 6.27 USD
52 Week Range 5.81 - 16.44 USD
Volume 6.3M USD
Avg. Volume 3.03M USD
Market Cap 1.32B USD
Beta (5Y Monthly) 1.223
PE Ratio (TTM) N/A
EPS (TTM) -1.44 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 25.73 USD

OCUL Valuation Measures

Enterprise Value 873.94M USD
Trailing P/E N/A
Forward P/E -3.7775156
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 26.288853
Price/Book (mrq) 3.0024936
Enterprise Value/Revenue 17.346
Enterprise Value/EBITDA -2.599

Trading Information

Ocular Therapeutix Stock Price History

Beta (5Y Monthly) 1.223
52-Week Change -50.24%
S&P500 52-Week Change 10.51%
52 Week High 16.44 USD
52 Week Low 5.81 USD
50-Day Moving Average 7.79 USD
200-Day Moving Average 8.87 USD

OCUL Share Statistics

Avg. Volume (3 month) 3.03M USD
Avg. Daily Volume (10-Days) 3.22M USD
Shares Outstanding 220.02M
Float 185.07M
Short Ratio 8.76
% Held by Insiders 0.90%
% Held by Institutions 95.42%
Shares Short 29M
Short % of Float 15.56%
Short % of Shares Outstanding 13.18%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -680.90%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -42.18%
Return on Equity (ttm) -93.48%

Income Statement

Revenue (ttm) 50.38M USD
Revenue Per Share (ttm) 0.23 USD
Quarterly Revenue Growth (yoy) -11.50%
Gross Profit (ttm) -201943008 USD
EBITDA -336256000 USD
Net Income Avi to Common (ttm) -326811008 USD
Diluted EPS (ttm) -1.44
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 530.61M USD
Total Cash Per Share (mrq) 2.41 USD
Total Debt (mrq) 80.01M USD
Total Debt/Equity (mrq) 18.15 USD
Current Ratio (mrq) 9.118
Book Value Per Share (mrq) 2.005

Cash Flow Statement

Operating Cash Flow (ttm) -253136992 USD
Levered Free Cash Flow (ttm) -159983872 USD

Profile of Ocular Therapeutix

Country United States
State MA
City Bedford
Address 14 Crosby Drive
ZIP 01730
Phone 781 357 4000
Website https://www.ocutx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 325

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Q&A For Ocular Therapeutix Stock

What is a current OCUL stock price?

Ocular Therapeutix OCUL stock price today per share is 5.94 USD.

How to purchase Ocular Therapeutix stock?

You can buy OCUL shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Ocular Therapeutix?

The stock symbol or ticker of Ocular Therapeutix is OCUL.

Which industry does the Ocular Therapeutix company belong to?

The Ocular Therapeutix industry is Biotechnology.

How many shares does Ocular Therapeutix have in circulation?

The max supply of Ocular Therapeutix shares is 220.02M.

What is Ocular Therapeutix Price to Earnings Ratio (PE Ratio)?

Ocular Therapeutix PE Ratio is now.

What was Ocular Therapeutix earnings per share over the trailing 12 months (TTM)?

Ocular Therapeutix EPS is -1.44 USD over the trailing 12 months.

Which sector does the Ocular Therapeutix company belong to?

The Ocular Therapeutix sector is Healthcare.

Ocular Therapeutix OCUL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.16B USD — 24225.3 USD — 24538.78 USD — — 7.16B USD —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
us US Tech Composite Total Return XCMP US 30190.38 USD —
+0.42
— — 29937.56 USD — 30324.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Biotechnology Total Retu XNBI US 7618.1 USD —
-0.66
— — 7605.28 USD — 7732.54 USD — — — —
us US Tech Global Market Composite NQGM US 1839.01 USD —
+0.18
— — 1830.2 USD — 1855.92 USD — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
$2.17T
Total marketcap
$71.26B
Total volume
BTC 58.00%   •   ETH 9.96%
Dominance
Select currency